Among patients with basal-like cancers, the population co-expressing both PKCλ and ALDH1A3 (43.7%; n = 87/199) was higher than that co-expressing PKCλ and ALDH1A1 (12.1%; n = 24/199) (Table 1). Here, ALDH1A3 is linked to cancer.